Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
UNIVERSITE DE BORDEAUX has 2 pending office actions in Biotechnology & Pharmaceuticals. The matters are divided between 2 examiners and 2 art units, showing that the current workload is spread across separate examination settings. This structure favors a coordinated disclosure review, but it also requires counsel to tailor claim amendments and arguments to each individual record.
KETCHAM, KAREN A is the busiest examiner, with 1 pending matter. One other matter remains with a different examiner and art unit. Counsel can use the shared technology area to identify consistent terminology and support, while treating the two office actions as distinct prosecution problems rather than one consolidated dispute.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KETCHAM, KAREN A | 1 | 19.6% | +37.2% |
| RUMP, RICHARD M | 1 | 74.4% | +20.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18694176 | USE OF WATER-SOLUBLE LIGNIN AS AN ANTI-UV FILTER | KETCHAM, KAREN A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17907801 | Graphenium dispersions and composites, process for making same, and uses thereof | RUMP, RICHARD M | 8d |
| 18694176 | USE OF WATER-SOLUBLE LIGNIN AS AN ANTI-UV FILTER | KETCHAM, KAREN A | — |
| Art Unit | Apps |
|---|---|
| 1614 | 1 |
| 1759 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18694176 | USE OF WATER-SOLUBLE LIGNIN AS AN ANTI-UV FILTER | KETCHAM, KAREN A | 1614 | §103§112 | Non-Final OA | — | Pending | Mar 21, 2024 |
| 17907801 | Graphenium dispersions and composites, process for making same, and uses thereof | RUMP, RICHARD M | 1759 | §112 | Final Rejection | 8d | Pending | Aug 29, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUNIVERSITE DE BORDEAUX has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Karen A Ketcham has the most, with 1 of UNIVERSITE DE BORDEAUX's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
